These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2431666)

  • 21. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium.
    Orntoft TF; Wolf H; Watkins WM
    Cancer Res; 1988 Aug; 48(15):4427-33. PubMed ID: 3134126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
    Proca E; Lucan M; Pîslăraşu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
    [No Abstract]   [Full Text] [Related]  

  • 24. A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma.
    Busch C; Malmström PU; Norlen BJ; Sällström J; Brodin T; Lundblad A
    Anticancer Res; 1988; 8(1):81-7. PubMed ID: 3358642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell surface antigen in bilharzial bladder tumours.
    Halim A; Javadpour N; Kasraeian A; Young JD
    Br J Urol; 1986 Oct; 58(5):523-5. PubMed ID: 3096417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple cell markers in bladder cancer. Principles and clinical applications.
    Javadpour N
    Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS; Miller AW; Coon JS
    Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prognosis of superficial urothelial tumors of the bladder. Evaluation possibilities using the erythrocyte adherence test (SRCA test)].
    Krüger R; Reuter F; Deilmann W
    Pathologe; 1982 Sep; 3(5):266-71. PubMed ID: 7145864
    [No Abstract]   [Full Text] [Related]  

  • 30. [The distribution of ABO-(H) isoantigens in tumors of the bladder].
    Baranyay F; Enzsöl C; Somogyi L
    Morphol Igazsagugyi Orv Sz; 1987 Apr; 27(2):123-7. PubMed ID: 3587245
    [No Abstract]   [Full Text] [Related]  

  • 31. Altered cell surface antigen expression in bladder carcinoma detected by a new hemagglutinating monoclonal antibody.
    Rearden A; Nachtsheim DA; Frisman DM; Chiu P; Elmajian DA; Baird SM
    J Immunol; 1983 Dec; 131(6):3073-7. PubMed ID: 6417241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A B H isoantigens in bladder cancer. Preliminary study].
    Hernáez Manrique I; Rodríguez Trinidad A; Gastaminza A; Recarte Mendiluce JM
    Actas Urol Esp; 1983; 7(2):113-6. PubMed ID: 6880907
    [No Abstract]   [Full Text] [Related]  

  • 37. Bladder tumors: when to do and what to expect from random mucosal biopsies with reference to blood group cell surface antigens.
    Boccon-Gibod L; Boccon-Gibod L; Desligneres S; Janin-Mercier A
    Eur Urol; 1987; 13(1-2):1-6. PubMed ID: 3582436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of blood group antigens and carcinoembryonic antigen in urinary bladder carcinoma.
    Fujioka T; Ohhori T; Lovrekovich L; deKernion JB
    Urol Int; 1986; 41(6):397-402. PubMed ID: 3547992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bladder tumors: prognostic value of surface antigens and carcinoembryonic antigens. A retrospective study].
    Hammou JC; Fella C; Vacant J; Veillon B; Brisset JM
    Ann Urol (Paris); 1984 Sep; 18(5):319-23. PubMed ID: 6529244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.